Ranatuerin-2PLx establishes cell apoptosis using caspase-3 against prostate cancer cell PC-3 [51], and Dermaseptins establishes pore formation of the prostate cancer cell PC-3 [52]. This evidence concerns the gene CASP3 and prostate cancer.